Glucose infusion partially attenuates glucose production and increases uptake during intense exercise. 1998

A Manzon, and S J Fisher, and J A Morais, and L Lipscombe, and M C Guimond, and S J Nessim, and R J Sigal, and J B Halter, and M Vranic, and E B Marliss
McGill Nutrition and Food Science Centre, Royal Victoria Hospital, Montreal, Quebec, Canada H3A 1A1, Canada.

Glucose infusion can prevent the increase in glucose production (Ra) and increase glucose uptake (Rd) during exercise of moderate intensity. We postulated that 1) because in postabsorptive intense exercise (>80% maximal O2 uptake) the eightfold increase in Ra may be mediated by catecholamines rather than by glucagon and insulin, exogenous glucose infusion would not prevent the Ra increment, and 2) such infusion would cause greater Rd. Fit young men were exercised at >85% maximal O2 uptake for 14 min in the postabsorptive state [controls (Con), n = 12] or at minute 210 of a 285-min glucose infusion. In seven subjects, the infusion was constant (CI; 4 mg . kg-1 . min-1), and in seven subjects it was varied (VI) to mimic the exercise Ra response in Con. Although glucose suppressed Ra to zero (with glycemia approximately 6 mM and insulin approximately 150 pM), an endogenous Ra response to exercise occurred, to peak increments two-thirds those in Con, in both CI and VI. Glucagon was unchanged, and very small increases in the glucagon-to-insulin ratio occurred in all three groups. Catecholamine responses were similar in all three groups, and correlation coefficients of Ra with plasma norepinephrine and epinephrine were significant in all. In all CI and VI, Rd at rest was 2x Con, increased earlier in exercise, and was higher for the 1 h of recovery with glucose infusion. Thus the Ra response was only partly attenuated, and the catecholamines are likely to be the regulators. This suggests that an acute endogenous Ra rise is possible even in the postprandial state. Furthermore, the fact that more circulating glucose is used by muscle during exercise and early recovery suggests that muscle glycogen is spared.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D010101 Oxygen Consumption The rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. (Stedman, 25th ed, p346) Consumption, Oxygen,Consumptions, Oxygen,Oxygen Consumptions
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002395 Catecholamines A general class of ortho-dihydroxyphenylalkylamines derived from TYROSINE. Catecholamine,Sympathin,Sympathins
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A Manzon, and S J Fisher, and J A Morais, and L Lipscombe, and M C Guimond, and S J Nessim, and R J Sigal, and J B Halter, and M Vranic, and E B Marliss
May 2000, American journal of physiology. Endocrinology and metabolism,
A Manzon, and S J Fisher, and J A Morais, and L Lipscombe, and M C Guimond, and S J Nessim, and R J Sigal, and J B Halter, and M Vranic, and E B Marliss
May 2001, The Journal of clinical endocrinology and metabolism,
A Manzon, and S J Fisher, and J A Morais, and L Lipscombe, and M C Guimond, and S J Nessim, and R J Sigal, and J B Halter, and M Vranic, and E B Marliss
May 2000, Journal of applied physiology (Bethesda, Md. : 1985),
A Manzon, and S J Fisher, and J A Morais, and L Lipscombe, and M C Guimond, and S J Nessim, and R J Sigal, and J B Halter, and M Vranic, and E B Marliss
June 1999, The American journal of physiology,
A Manzon, and S J Fisher, and J A Morais, and L Lipscombe, and M C Guimond, and S J Nessim, and R J Sigal, and J B Halter, and M Vranic, and E B Marliss
April 1981, Journal of applied physiology: respiratory, environmental and exercise physiology,
A Manzon, and S J Fisher, and J A Morais, and L Lipscombe, and M C Guimond, and S J Nessim, and R J Sigal, and J B Halter, and M Vranic, and E B Marliss
September 1989, The American journal of physiology,
A Manzon, and S J Fisher, and J A Morais, and L Lipscombe, and M C Guimond, and S J Nessim, and R J Sigal, and J B Halter, and M Vranic, and E B Marliss
January 2006, American journal of physiology. Endocrinology and metabolism,
A Manzon, and S J Fisher, and J A Morais, and L Lipscombe, and M C Guimond, and S J Nessim, and R J Sigal, and J B Halter, and M Vranic, and E B Marliss
December 1993, The American journal of physiology,
A Manzon, and S J Fisher, and J A Morais, and L Lipscombe, and M C Guimond, and S J Nessim, and R J Sigal, and J B Halter, and M Vranic, and E B Marliss
February 1981, Diabetes,
A Manzon, and S J Fisher, and J A Morais, and L Lipscombe, and M C Guimond, and S J Nessim, and R J Sigal, and J B Halter, and M Vranic, and E B Marliss
January 1998, Medicine and science in sports and exercise,
Copied contents to your clipboard!